Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma

S. A. Nicholson, N. T. Okby, M. A. Khan, J. A. Welsh, M. G. McMenamin, W. D. Travis, J. R. Jett, H. D. Tazelaar, V. Trastek, P. C. Pairolero, P. G. Corn, J. G. Herman, L. A. Liotta, N. E. Caporaso, C. C. Harris

Research output: Contribution to journalArticle

Abstract

Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the 1NK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53, it has been proposed that the loss of p14ARF is functionally equivalent to a p53 mutation. We have tested this hypothesis by examining the genomic status of the unique exon 1β of p14ARF in 53 human cell lines and 86 primary non-small cell lung carcinomas and correlated this with previously characterized alterations of p53. Homozygous deletions of p14ARF were detected in 12 of 53 (23%) cell lines and 16 of 86 (19%) primary tumors. A single cell line, but no primary tumors, harbored an intragenic mutation. The deletion of p14ARF was inversely correlated with the loss of p53 in the majority of cell lines (P = 0.02), but this relationship was not maintained among primary tumors (P = 0.5). E2F-1 can also induce p73 via a p53-independent apoptotic pathway. Although we did not observe inactivation of p73 by either mutation or DNA methylation, haploinsufficiency of p73 correlated positively with either p14ARF or p53 mutation or both (P = 0.01) in primary non-small cell lung carcinomas. These data are consistent with the current model of p14ARF and p53 interaction as a complex network rather than a simple linear pathway and indicate a possible role for an E2F-1-mediated failsafe, p53-independent, apoptotic pathway involving p73 in human lung carcinogenesis.

Original languageEnglish (US)
Pages (from-to)5636-5643
Number of pages8
JournalCancer Research
Volume61
Issue number14
StatePublished - Jul 15 2001

Fingerprint

Tumor Suppressor Protein p14ARF
p53 Genes
Non-Small Cell Lung Carcinoma
Cell Line
Mutation
Neoplasms
Carcinogenesis
Haploinsufficiency
Lung
DNA Methylation
Exons
Apoptosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nicholson, S. A., Okby, N. T., Khan, M. A., Welsh, J. A., McMenamin, M. G., Travis, W. D., ... Harris, C. C. (2001). Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Research, 61(14), 5636-5643.

Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. / Nicholson, S. A.; Okby, N. T.; Khan, M. A.; Welsh, J. A.; McMenamin, M. G.; Travis, W. D.; Jett, J. R.; Tazelaar, H. D.; Trastek, V.; Pairolero, P. C.; Corn, P. G.; Herman, J. G.; Liotta, L. A.; Caporaso, N. E.; Harris, C. C.

In: Cancer Research, Vol. 61, No. 14, 15.07.2001, p. 5636-5643.

Research output: Contribution to journalArticle

Nicholson, SA, Okby, NT, Khan, MA, Welsh, JA, McMenamin, MG, Travis, WD, Jett, JR, Tazelaar, HD, Trastek, V, Pairolero, PC, Corn, PG, Herman, JG, Liotta, LA, Caporaso, NE & Harris, CC 2001, 'Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma', Cancer Research, vol. 61, no. 14, pp. 5636-5643.
Nicholson SA, Okby NT, Khan MA, Welsh JA, McMenamin MG, Travis WD et al. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Research. 2001 Jul 15;61(14):5636-5643.
Nicholson, S. A. ; Okby, N. T. ; Khan, M. A. ; Welsh, J. A. ; McMenamin, M. G. ; Travis, W. D. ; Jett, J. R. ; Tazelaar, H. D. ; Trastek, V. ; Pairolero, P. C. ; Corn, P. G. ; Herman, J. G. ; Liotta, L. A. ; Caporaso, N. E. ; Harris, C. C. / Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. In: Cancer Research. 2001 ; Vol. 61, No. 14. pp. 5636-5643.
@article{60205119560d4062bdcb19fbaa3fecbd,
title = "Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma",
abstract = "Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the 1NK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53, it has been proposed that the loss of p14ARF is functionally equivalent to a p53 mutation. We have tested this hypothesis by examining the genomic status of the unique exon 1β of p14ARF in 53 human cell lines and 86 primary non-small cell lung carcinomas and correlated this with previously characterized alterations of p53. Homozygous deletions of p14ARF were detected in 12 of 53 (23{\%}) cell lines and 16 of 86 (19{\%}) primary tumors. A single cell line, but no primary tumors, harbored an intragenic mutation. The deletion of p14ARF was inversely correlated with the loss of p53 in the majority of cell lines (P = 0.02), but this relationship was not maintained among primary tumors (P = 0.5). E2F-1 can also induce p73 via a p53-independent apoptotic pathway. Although we did not observe inactivation of p73 by either mutation or DNA methylation, haploinsufficiency of p73 correlated positively with either p14ARF or p53 mutation or both (P = 0.01) in primary non-small cell lung carcinomas. These data are consistent with the current model of p14ARF and p53 interaction as a complex network rather than a simple linear pathway and indicate a possible role for an E2F-1-mediated failsafe, p53-independent, apoptotic pathway involving p73 in human lung carcinogenesis.",
author = "Nicholson, {S. A.} and Okby, {N. T.} and Khan, {M. A.} and Welsh, {J. A.} and McMenamin, {M. G.} and Travis, {W. D.} and Jett, {J. R.} and Tazelaar, {H. D.} and V. Trastek and Pairolero, {P. C.} and Corn, {P. G.} and Herman, {J. G.} and Liotta, {L. A.} and Caporaso, {N. E.} and Harris, {C. C.}",
year = "2001",
month = "7",
day = "15",
language = "English (US)",
volume = "61",
pages = "5636--5643",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma

AU - Nicholson, S. A.

AU - Okby, N. T.

AU - Khan, M. A.

AU - Welsh, J. A.

AU - McMenamin, M. G.

AU - Travis, W. D.

AU - Jett, J. R.

AU - Tazelaar, H. D.

AU - Trastek, V.

AU - Pairolero, P. C.

AU - Corn, P. G.

AU - Herman, J. G.

AU - Liotta, L. A.

AU - Caporaso, N. E.

AU - Harris, C. C.

PY - 2001/7/15

Y1 - 2001/7/15

N2 - Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the 1NK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53, it has been proposed that the loss of p14ARF is functionally equivalent to a p53 mutation. We have tested this hypothesis by examining the genomic status of the unique exon 1β of p14ARF in 53 human cell lines and 86 primary non-small cell lung carcinomas and correlated this with previously characterized alterations of p53. Homozygous deletions of p14ARF were detected in 12 of 53 (23%) cell lines and 16 of 86 (19%) primary tumors. A single cell line, but no primary tumors, harbored an intragenic mutation. The deletion of p14ARF was inversely correlated with the loss of p53 in the majority of cell lines (P = 0.02), but this relationship was not maintained among primary tumors (P = 0.5). E2F-1 can also induce p73 via a p53-independent apoptotic pathway. Although we did not observe inactivation of p73 by either mutation or DNA methylation, haploinsufficiency of p73 correlated positively with either p14ARF or p53 mutation or both (P = 0.01) in primary non-small cell lung carcinomas. These data are consistent with the current model of p14ARF and p53 interaction as a complex network rather than a simple linear pathway and indicate a possible role for an E2F-1-mediated failsafe, p53-independent, apoptotic pathway involving p73 in human lung carcinogenesis.

AB - Overexpression of E2F-1 induces apoptosis by both a p14ARF-p53- and a p73-mediated pathway. p14ARF is the alternate tumor suppressor product of the 1NK4a/ARF locus that is inactivated frequently in lung carcinogenesis. Because p14ARF stabilizes p53, it has been proposed that the loss of p14ARF is functionally equivalent to a p53 mutation. We have tested this hypothesis by examining the genomic status of the unique exon 1β of p14ARF in 53 human cell lines and 86 primary non-small cell lung carcinomas and correlated this with previously characterized alterations of p53. Homozygous deletions of p14ARF were detected in 12 of 53 (23%) cell lines and 16 of 86 (19%) primary tumors. A single cell line, but no primary tumors, harbored an intragenic mutation. The deletion of p14ARF was inversely correlated with the loss of p53 in the majority of cell lines (P = 0.02), but this relationship was not maintained among primary tumors (P = 0.5). E2F-1 can also induce p73 via a p53-independent apoptotic pathway. Although we did not observe inactivation of p73 by either mutation or DNA methylation, haploinsufficiency of p73 correlated positively with either p14ARF or p53 mutation or both (P = 0.01) in primary non-small cell lung carcinomas. These data are consistent with the current model of p14ARF and p53 interaction as a complex network rather than a simple linear pathway and indicate a possible role for an E2F-1-mediated failsafe, p53-independent, apoptotic pathway involving p73 in human lung carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0035878072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035878072&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 5636

EP - 5643

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 14

ER -